European Medicines Agency to appeal Brexit lease case

25 April 2019 - The European Medicines Agency, one of the EU's biggest regulators, is appealing against a London ruling ...

Read more →

No-deal risk recedes, but new Brexit delay adds to uncertainty

12 April 2019 - Delay means industry must sustain no-deal investment. ...

Read more →

No-deal Brexit could mean temporary medicines export ban

1 April 2019 - The Association of the British Pharmaceutical Industry has called for a temporary ban on drugs exports ...

Read more →

EMA tells pharma companies to continue to prepare for UK’s withdrawal

25 March 2019 - With an extension in place that will push the UK's withdrawal from the EU back to ...

Read more →

Unprecedented drug shortage linked to Brexit, NHS bosses say

20 March 2019 - Hospitals across England are experiencing medicine shortages due to "stockpiling and price pressure as the Brexit ...

Read more →

The shadow of Brexit on speed of access

20 March 2019 - No-one can miss the ongoing saga that is the UK’s exit from the European Union.  ...

Read more →

Brexit - implications for therapeutic goods in Australia

18 March 2019 - In the event of a 'no deal' exit of the United Kingdom from the European Union, ...

Read more →

Pharma urges politicians to stop no-deal Brexit in today’s vote

13 March 2019 - Pharma has urged politicians to reject a no-deal Brexit in today’s crunch vote, reiterating warnings that ...

Read more →

Pharma industry swamped with no-deal Brexit info, says BIA

27 February 2019 - Deluge comes just as prime minister hints at delay. ...

Read more →

How will Brexit affect health services in the UK? An updated evaluation

25 February 2019 - All forms of Brexit are bad for health, but some are worse than others.  ...

Read more →

Brexit doesn't mean EU agency can break Canary Wharf lease

20 February 2019 - EU departure doesn’t allow medicines agency to break its lease. ...

Read more →

Brexit: will Britons living in the EU still get health care?

18 February 2019 - If the UK leaves the EU without a deal, reciprocal health care arrangements will not automatically ...

Read more →

EU, America and China will all get new medicines ahead of Britain after Brexit, drug company boss warns

14 February 2019 - David Meek, the CEO of Ipsen, warns Britain leaving the European Union has seen the country fall ...

Read more →

Fake drugs could put patients at risk after no-deal Brexit

8 February 2019 - Patients could be put at risk from fake medicines if the UK exits the EU without ...

Read more →

What will a no-deal Brexit mean for pharma and health care?

7 February 2019 - Britons are bracing themselves for the UK’s imminent departure from the European Union. A worst-case scenario ...

Read more →